ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2107

Pregnancy Outcomes Among Women with Systemic Lupus Erythematosus (SLE): Impact of Preexisting Hypertension

azalfa Lateef1, stephanie Bray2, Dulaney Wilson2, Jim Oates2 and Diane Kamen2, 1MUSC, Columbia, SC, 2Medical University of South Carolina, Charleston, SC

Meeting: ACR Convergence 2022

Keywords: pregnancy, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2022

Title: SLE – Diagnosis, Manifestations, and Outcomes Poster III: Outcomes

Session Type: Poster Session D

Session Time: 1:00PM-3:00PM

Background/Purpose: Advances in medicine for women with systemic lupus erythematosus (SLE) have led to improved pregnancy outcomes, but pregnancies are still high-risk and disparities remain. Hypertension (HTN) rates are higher among women with SLE compared to non-SLE controls. The goal of our study is to examine the effect HTN has on pregnancy outcomes among women with SLE.

Methods: Women with SLE and at least one pregnancy who were enrolled in a single center longitudinal prospective registry were included. Self-reported pregnancy outcomes included live births, spontaneous abortion, pre-term birth, low birth weight, and pre-eclampsia, while elective abortions were excluded. Pregnancies were classified as 1) before SLE diagnosis or 2) during(peri)/after SLE diagnosis and as either 1) with preexisting HTN or 2) without preexisting HTN (including those with HTN diagnosed after delivery). Differences by groups were evaluated with chi-square test of homogeneity or Fishers exact test. The association of pregnancy outcomes with HTN was evaluated with logistic regression; SLE diagnosis and race were evaluated as potential confounders.

Results: The analytic cohort consisted of 873 pregnancies among 365 women with SLE (275 (75.3%) Black), of which 685 (78.5%) of the pregnancies were among Black mothers. Women without SLE and those without a known pregnancy history were excluded. Demographics and clinical characteristics are described in Table 1. Each woman had an average of 2.4 ± 1.3 pregnancies. 60.1% of the women had been diagnosed with HTN at some point in their life, 22.0% with HTN prior to their first pregnancy.

Of the 873 pregnancies, there were 718 live births, 21 still births and 134 miscarriages (Table 2). The highest proportion of overall adverse pregnancy outcomes was among mothers with HTN prior to pregnancy and SLE diagnosed at the time of pregnancy or following pregnancy. Mothers who had diagnoses of HTN and SLE prior to pregnancy had the highest number of spontaneous abortions (Figure 1).

Conclusion: Preexisting HTN in women with SLE negatively impacted their pregnancy outcomes, though complicated by race and the timing of SLE diagnosis. Our results emphasize the importance of knowing potentially modifiable risk factors like HTN and the need for earlier SLE screening / diagnosis to improve pregnancy outcomes in this population.

Supporting image 1

Supporting image 2

Supporting image 3

Figure 1. Proportions of Adverse Pregnancy Outcomes in Relation to Timing of HTN and SLE Diagnoses


Disclosures: a. Lateef, None; s. Bray, None; D. Wilson, None; J. Oates, None; D. Kamen, None.

To cite this abstract in AMA style:

Lateef a, Bray s, Wilson D, Oates J, Kamen D. Pregnancy Outcomes Among Women with Systemic Lupus Erythematosus (SLE): Impact of Preexisting Hypertension [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/pregnancy-outcomes-among-women-with-systemic-lupus-erythematosus-sle-impact-of-preexisting-hypertension/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pregnancy-outcomes-among-women-with-systemic-lupus-erythematosus-sle-impact-of-preexisting-hypertension/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology